T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report)’s stock price passed above its 50-day moving average during trading on Thursday . The stock has a 50-day moving average of $0.01 and traded as high as $0.0180. T2 Biosystems shares last traded at $0.0127, with a volume of 7,988 shares trading hands.
T2 Biosystems Stock Performance
The firm has a market capitalization of $267,246.10, a price-to-earnings ratio of 0.00 and a beta of 0.73. The company has a 50-day moving average price of $0.01 and a 200-day moving average price of $0.04.
T2 Biosystems Company Profile
T2 Biosystems, Inc is a commercial‐stage diagnostics company focused on developing and marketing innovative, rapid diagnostic products designed to improve patient outcomes and reduce healthcare costs. The company’s proprietary T2 Magnetic Resonance (T2MR) technology enables direct detection of pathogens and biomarkers in whole blood without the need for culture, delivering results in hours rather than days. T2 Biosystems’ core mission is to provide clinicians with faster, actionable data to guide treatment decisions, particularly in the management of sepsis, bloodstream infections and other life‐threatening conditions.
The flagship product, the T2Dx® Instrument, serves as the platform for all T2 assays.
Recommended Stories
- Five stocks we like better than T2 Biosystems
- Why Invest in High-Yield Dividend Stocks?
- These 3 Banks Are Rallying Into Year-End, But Will It Continue?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- 3 Surging Stocks Just Got the Ultimate Stamp of Approval From the S&P 500
- Low PE Growth Stocks: Unlocking Investment Opportunities
- This ETF Caught a Major Tailwind After the Fed’s Rate Cut
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
